» Articles » PMID: 26960544

Effects of Quercetin on Chronic Constriction Nerve Injury in an Experimental Rat Model

Overview
Specialty Neurosurgery
Date 2016 Mar 11
PMID 26960544
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Flavonoids are popular substances in the literature, with proven effects on cardiovascular, neoplastic and neurodegenerative diseases. Antioxidant effect is the most pronounced and studied one. Among thousands of flavonoids, quercetin (QUE) is a prototype with significant antioxidant effects. This study aims to demonstrate the effects of QUE in an experimental rat model of chronic constriction injury (CCI).

Method: A two-level study was designed with 42 adult Wistar rats that were randomly assigned to different groups. In the first part, animals in sham, control, quercetin, morphine and gabapentine groups received chronic constriction injury to their sciatic nerves and received a single dose of QUE, morphine and gabapentine. In the second part, different dose regimens of QUE were administered to different groups of animals. Pre-injury and post-injury assessments for mechanical hypersensitivity, thermal sensitivity, locomotor activity and anxiety were recorded and statistical comparisons were performed between different groups.

Results: Comparison of QUE with morphine and gabapentine has revealed significant effects of this agent in the current chronic constriction injury model. QUE was significantly superior to Gabapentine and morphine in terms of alleviating mechanical and thermal hypersensitivity. Additionally, pre-injury administration of QUE for 4 days demonstrated long-term effectiveness on mechanical hypersensitivity.

Conclusions: This preliminary report the on effects of QUE in a chronic constriction injury model proved significant effects of the agent, which should be supplemented with different studies using different dose regimens.

Citing Articles

Biomarkers and signaling pathways of diabetic nephropathy and peripheral neuropathy: possible therapeutic intervention of rutin and quercetin.

Roohi T, Mehdi S, Aarfi S, Krishna K, Pathak S, Suhail S Diabetol Int. 2024; 15(2):145-169.

PMID: 38524936 PMC: 10959902. DOI: 10.1007/s13340-023-00680-8.


Targeting Oxidative Stress, Autophagy, and Apoptosis by Quercetin to Ameliorate Cisplatin-induced Peripheral Neuropathy in Rats.

Mahmoud H, Horany H, Aboalsoud M, Abd-Ellatif R, Sheikh A, Aboalsoud A J Microsc Ultrastruct. 2023; 11(2):107-114.

PMID: 37448816 PMC: 10337675. DOI: 10.4103/jmau.jmau_78_22.


Quercetin Derivatives in Combating Spinal Cord Injury: A Mechanistic and Systematic Review.

Fakhri S, Gravandi M, Abdian S, Moradi S, Echeverria J Life (Basel). 2022; 12(12).

PMID: 36556325 PMC: 9783198. DOI: 10.3390/life12121960.


The Emerging Role of Quercetin in the Treatment of Chronic Pain.

Liu C, Liu D, Tian Y, Mei W, Tian X, Xu A Curr Neuropharmacol. 2022; 20(12):2346-2353.

PMID: 35959909 PMC: 9890298. DOI: 10.2174/1570159X20666220812122437.


The Impact of Supplements on Recovery After Peripheral Nerve Injury: A Review of the Literature.

Abushukur Y, Knackstedt R Cureus. 2022; 14(5):e25135.

PMID: 35733475 PMC: 9205410. DOI: 10.7759/cureus.25135.